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Katarzyna Murat1, Björn Grüning 2, Paulina Wiktoria Poterlowicz3,
Gillian Westgate1, Desmond J. Tobin4 and Krzysztof Poterlowicz 1,*
1Center for Skin Sciences, University of Bradford, Richmond Road, Bradford BD7 1DP, UK; 2Freiburg Galaxy
Team, University of Freiburg, Fahnenbergplatz, 79085 Freiburg im Breisgau, Germany; 3Hull York Medical
School, University of York, University Rd, York Y010 5DD, UK and 4The Charles Institute for Dermatology,
Belfield, School of Medicine, University College Dublin, Ireland
∗Correspondence address. Krzysztof Poterlowicz, Center for Skin Sciences, University of Bradford, Richmond Road, Bradford BD7 1DP, UK. E-mail:
k.poterlowicz1@bradford.ac.uk http://orcid.org/0000-0001-6173-5674
Abstract
Background: Infinium Human Methylation BeadChip is an array platform for complex evaluation of DNA methylation at an
individual CpG locus in the human genome based on Illumina’s bead technology and is one of the most common
techniques used in epigenome-wide association studies. Finding associations between epigenetic variation and phenotype
is a significant challenge in biomedical research. The newest version, HumanMethylationEPIC, quantifies the DNA
methylation level of 850,000 CpG sites, while the previous versions, HumanMethylation450 and HumanMethylation27,
measured >450,000 and 27,000 loci, respectively. Although a number of bioinformatics tools have been developed to analyse
this assay, they require some programming skills and experience in order to be usable. Results: We have developed a
pipeline for the Galaxy platform for those without experience aimed at DNA methylation analysis using the Infinium
Human Methylation BeadChip. Our tool is integrated into Galaxy (http://galaxyproject.org), a web-based platform. This
allows users to analyse data from the Infinium Human Methylation BeadChip in the easiest possible way. Conclusions: The
pipeline provides a group of integrated analytical methods wrapped into an easy-to-use interface. Our tool is available from
the Galaxy ToolShed, GitHub repository, and also as a Docker image. The aim of this project is to make Infinium Human
Methylation BeadChip analysis more flexible and accessible to everyone.
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Background
Over the past several years comprehensive sequencing datasets
have been generated, allowing analysis of genome-wide activity
in cohorts of different individuals to be increasingly available.
Infinium Human Methylation BeadChip requires only a few days
to produce methylome profiles of human samples with a low
sample input requirement (as low as 500 ng of genomic DNA) for
the starting material [1]. Studies performed recently have identi-
fied variation naturally occurring in the genome associated with
disease risk and prognosis, including tumour pathogenesis [2].
This raised interest in the concept of epigenome-wide associa-
tion studies (EWAS). The term “epigenome” means “on top of the
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genome” and refers to specific changes in genome regulatory ac-
tivity occurring in response to environmental stimuli [3]. Epige-
netic modifications do not change the underlying DNA sequence
but can cause multiple changes in gene expression and cellular
function [4]. In humans, DNA methylation occurs by attaching a
methyl group to the cytosine residue. This has been suggested as
a suppressor of gene expression [5]. Multiple methods for DNA
methylation analysis were developed, including PCR and pyrose-
quencing of bisulfite converted DNA, dedicated to studying a
small number of methylation sites across a number of samples
[6]. Assays like whole-genome bisulfite sequencing and reduced
representation bisulfite sequencing allow global quantification
of DNA methylation levels. However, running this type of analy-
sis for a larger number of samples can be prohibitively laborious
and expensive [7]. The Infinium Human Methylation BeadChip
[1] offers unprecedented applicability and affordability owinng
to the low costs of reagents, short time of processing, high accu-
racy, and low input DNA requirements. It determines quantita-
tive array-based methylation measurements at the single-CpG-
site level of >850,000 loci [8], covering most of the promoters
and also numerous other loci. This makes this assay suitable
for systematic investigation of methylation changes in normal
and diseased cells [3]. As such it has become one of the most
comprehensive solutions on the market [9]. However, Illumina
commercial software generates additional costs and is not suit-
able for everyone. Therefore there is a need to create freely avail-
able software able to perform comprehensive analysis includ-
ing quality control, normalization, and detection of differentially
methylated regions (DMRs) [9]. Open source software packages
(e.g., DMRcate [10], Minfi [11], ChAMP [12], methylumi [13], Rn-
Beads [14]) require high-performance computational hardware
as well as command line experience in order to run the anal-
ysis. This is why one of the aims of the our Infinium Human
Methylation BeadChip pipeline was to set and implement these
methods into a user-friendly environment. The tool has been de-
veloped to provide users with an enhanced understanding of the
Infinium Human Methylation BeadChip analysis. The workflow
includes methods for preprocessing with a stratified quantile
normalization preprocess. It includes quantile or extended im-
plementation of the functional normalization preprocess Fun-
norm with unwanted variation removal, sample-specific qual-
ity assessment, and methodology for calling DMR and differen-
tially methylated position (DMP) detection. Scripts were com-
bined and published on the web-based platform Galaxy, a graph-
ical interface with tools and ready-to-run workflows providing
a solution for non-programmer scientists to analyse their data
and share their experience with others [15]. Configuration files
are publicly shared on our GitHub repository [16], with code and
dependency settings also available to download and install via
the Galaxy ToolShed [17]. Our tool was created and tested using
Planemo [18], an integrated workspace for Galaxy tool develop-
ment with a default configuration and shed tool set-up available
via Docker (operating system–level virtualization) [16].
Tool Description
The workflow combines 5 main steps (see Fig. 1), starting with
raw intensity data loading (/.idat) and then preprocessing and
optional normalization of the data. The next quality control
step performs an additional sample check to remove low-quality
data, which normalization cannot detect. The workflow gives
the user the opportunity to perform any of these preparation and
data-cleaning steps, including the next highly recommended
genetic variation annotation step resulting in single-nucleotide
polymorphism (SNP) identification and removal. Finally, the
dataset generated through all of these steps can be used to find
DMPs and DMRs with respect to a phenotype covariate. All the
steps, as well as simple preparation and analysis options, are
shown in Fig. 2 and explained in detail below.
Data loading
The Infinium Human Methylation BeadChip assay interrogates
fluorescent signals (green and red) from the methylated and un-
methylated sites into binary values that can be read directly as
IDAT files [1]. Illumina’s GenomeStudio (GenomeStudio, RRID:SC
R 010973) solution converts the data into plain-text ASCII files,
losing a large amount of information during this process [19]. To
prevent this kind of data loss we introduced an R-based .IDAT
file-loading method, which is a combination of illuminaio rea-
dIDAT and minfi RGChannelSet functions. It reads intensity in-
formation from both treatment and control data and based on
this it builds up a specific joined dataset.
Preprocessing and normalization
Green and red channel signals from .IDAT files can be con-
verted into methylated and unmethylated signals assigned to
methylation levels or β values. β are built in RatioSet object,
and they estimate the methylation level using channel ratios
in a range between 0 and 1, with 0 being unmethylated and
1 being fully methylated [19]. However, these 2 classes can
also be preprocessed and normalized with 2 methods available
[19]. Preprocess Quantile implements stratified quantile nor-
malization preprocessing and is supported for small changes
such as in 1-type samples, e.g., blood datasets. In contrast,
preprocess Funnorm is aimed at global biological differences
such as healthy and occurred datasets with different tissue
and cell types. This is called the “between-array normalization
method” and removes unwanted variation [19]. In addition un-
wanted probes containing either an SNP at the CpG interro-
gation or at the single-nucleotide extension can be removed
(recommended) [19].
Quality assessment and control
Data quality assurance is an important step in Infinium Human
Methylation BeadChip analysis. The quality control function ex-
tracts and plots the data frame with 2 columns mMed and uMed,
which are the medians of MethylSet signals (Meth and Unmeth).
Comparing these against one another allows users to detect and
remove low-quality samples that normalization cannot correct
[11].
Annotating probes affected by genetic variation
SNP regions may affect results of downstream analysis. The Re-
move SNPs step returns data frames containing the SNP infor-
mation of unwanted probes and removes them from the dataset
[19].
DMP and DMR identification
The main goal of the Infinium Human Methylation BeadChip
tool is to simplify the way differentially methylated locus
sites are detected. The workflow contains a function detecting
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Figure 1: Simplified workflow for analysing epigenetics data.
Figure 2: Screenshot from the Galaxy interface, showing Infinium Human Methylation BeadChip workflow as discussed in the case study section.
for finding DMRs [11]. DMRs can be tracked using a bump-
hunting algorithm. The algorithm first implements a t-statistic
at each methylated locus location, with optional smoothing,
then groups probes into clusters with a maximum location gap
and a cut-off size to refer the lowest possible value of genomic
profile hunted by our tool [20].
Functional annotation and visualization
In addition to downstream analysis, users can access annota-
tions provided via Illumina by ChIPpeakAnno (ChIPpeakAnno,
RRID:SCR 012828) annoPeaks tool [19] or perform additional
functional annotations using the Gene Ontology (GO) via Cluster
Profiler GO tool. The GO tool provides a very detailed represen-
tation of functional relationships between biological processes,
molecular function, and cellular components across data [21].
Once specific regions have been chosen, Cluster Profiler GO visu-
alizes enrichment results (see Fig. 3). Many researchers use an-
notation analysis to characterize the function of genes, which
highlights the potential for Galaxy to be a solution for wide-
ranging multi-omics research.
Documentation and training
We have also provided training sessions and interactive tours for
user self-learning. The training materials are freely accessible at
the Galaxy (Galaxy, RRID:SCR 006281) project Github repository
[22]. Such training and tours guide users through an entire anal-
ysis. The following steps and notes help users to explore and
better understand the concept. Slides and hands-on instruction
describe the analysis workflow, and all necessary input files are
ready to use via Zenodo [23], as well as a Galaxy Interactive Tour,
and a tailor-made Galaxy Docker image for the corresponding
data analysis.
Case study
Compared to genetic studies EWAS provides a unique oppor-
tunity to study dynamic response to treatment. It has been
suggested that DNA methylation is associated with drug re-
sistance [24]. To validate our suite we have performed analy-
sis of differentially methylated regions using publicly available
data from the Infinium Human Methylation BeadChip array of
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Figure 3: Functional annotation of DMRs found in melanoma biopsies before and after MAPKi treatment.
Figure 4: Quality control plot representing median intensity of melanoma in
samples before and after MAPKi treatment. The plot compares median total in-
tensity (log2) of the methylated channel (x-axis) and unmethylated channel (y-
axis). Bad-quality samples fall under the threshold and are colored red. There is
no bad-quality sample in this study
kinase inhibitor (MAPKi) treatment [25], obtained from the Gene
Expression Omnibus (GEO) (GSE65183). Methylation profiling by
genome tiling array in melanoma can help us understand how
non-genomic and immune changes can have an impact on treat-
ment efficiency and disease progression. Raw image IDAT files
were loaded into the Galaxy environment using Data Libraries.
EWAS workflow was run on Red and Green dataset collections
of patient-matched melanoma tumours biopsied before ther-
apy and during disease progression. The IDAT files, predefined
phenotype tables, and up-to-date genome tables (UCSC Main
on Human hg19 Methyl450) [16] were used as inputs. To detect
poorly performing samples we ran quality diagnostics. The pro-
vided samples passed the quality control test (in Fig. 4 ) because
they clustered together with higher median intensities, confirm-
ing their good quality [19]. Differentially methylated loci were
identified using single-probe analysis implemented by our tool
with the following parameters: phenotype set as “categorical”
and qCutoff size set to 0.05. The bump-hunting algorithm was
applied to identify DMRs with maximum location gap param-
eter set to 250, genomic profile above the cut-off equal to 0.1,
number of resamples set to 0, and null method set to “permuta-
tion and verbose equal FALSE,” which means that no additional
progress information will be printed. Differentially Methylated
Regions and Positions revealed the need for further investigation
of tissue diversity in response to environmental changes [26].
The nearest transcription start sites found in the gene set can
be listed as follows: PITX1, SFRP2, MSX1, MIR21, AXIN2, GREM1,
WT1, CBX2, HCK, GTSE1, SNCG, PDPN, PDGFRA, NAF1, FGF5,
FOXE1, THBS1, DLK1, and HOX gene family. The results of the
re-analysis are available in the GitHub repository [27].
Important findings
Although hypermethylated genes identified by “EWAS-suite”
have been previously associated with cancer, this is the first
time a link between them and MAPKi treatment resistance is re-
ported. This data demonstrates the presence of platelet-derived
growth factor receptor (PDGFR), which is suggested to be respon-
sible for RAS/MAPK pathway signaling. Trough activation may
regulate the MAPKi mechanism in non-responsive tumours. The
methylation regulation of this altered status of PDGFR requires
additional studies [25]. The PITX1 suppressor gene was found
as one of the factors decreasing gene expression in human cu-
taneous malignant melanoma and might contribute to progres-
sion and resistance via promoting cell proliferative activity [28].
It has been found that the homeodomain transcription factor
MSX1 and the CBX2 polycomb group protein are likely to be
treatment resistance factors and are reported as downregulated
and inactivated in melanoma tumours [29]. Previous published
studies are limited to local surveys and serial biopsies. Thus,
the stimulus of innate or acquired MAPKi resistance may be
linked to epigenetics. GO annotation provides information re-
garding the function of genes [30]. GO analysis identified the pat-
tern specification process (GO:0007389), skeletal system devel-
opment (GO:0001501), and regionalization (GO:000300) as signif-
icantly overrepresented categories within the above DMRs, sug-
gesting that melanoma MAPKi resistance could be related to the
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Conclusion
With the rapidly increasing volume of epigenetics data available,
computer-based analysis of heritable changes in gene expres-
sion becomes more and more feasible. Many genome-wide epi-
genetics studies have focused on generation of data, with data
interpretation now being the challenge. Risk evaluation, disease
management, and novel therapeutic development are prompt-
ing researchers to find new bioinformatic frameworks and ap-
proaches. In this regard we propose a user-friendly tool suite
available via Galaxy platform. Ewastools allows life scientists to
run complex epigenetics analysis [16]. The case study presented
provides a tangible example of how population epigenetics anal-
ysis can provide additional insights into melanoma therapeutic
resistance.
Availability of Source Code and Requirements
 Project name: Ewastools: Infinium Human Methylation Bead-
Chip pipeline for population epigenetics integrated into
Galaxy
 Project home page: https://github.com/kpbioteam/ewas gal
axy
 Operating system(s): Linux (recommended), Mac
 Programming language: R programming language (version
3.3.2, x86 64bit)
 Other requirements: Galaxy [22], Docker [31]
 License: MIT License
 biotoolsID identifier: https://bio.tools/ewastools
 RRID:SCR 018085
Availability of Supporting Data and Materials
The test dataset in this article is available in the GEO database
under accession GSE65186. The results of the re-analysis of the
GSE65186 dataset are available in the GitHub repository (http
s://github.com/kpbioteam/ewastools-case study). All tools de-
scribed here are available in the Galaxy ToolShed (https://toolsh
ed.g2.bx.psu.edu). The Dockerfile required to automatically de-
ploy the pre-built Docker image is available at https://galaxypr
oject.org/use/ewas-galaxy/. Archival snapshots of the code are
available in the GigaScience GigaDB repository [32].
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